COVID-19 update

  • Posted

MEOPAR is fully aware that the current situation regarding the Coronavirus disease (COVID-19) is having a significant impact on the research community, both in Canada and internationally. We anticipate that the precise nature of these impacts may evolve over the coming weeks and months, and we note that projects may be unavoidably delayed as a result of practical measures taken to contain the virus.

Our priority is the safety and wellbeing of people—researchers and those who support them, including our own teams, HQP and partners. As a result, the MEOPAR administrative office will be working remotely for the foreseeable future—moving all scheduled meetings online—in efforts to minimize risk and practice social distancing. As part of this, we ask that all communication be initiated by email at this time. We will be monitoring info@meopar.ca closely but ask that you reach out directly to the individual you require assistance from for the most timely response.

On an ongoing basis, we are working to understand the nature of any impacts on our funded projects and to facilitate any appropriate measures that may prove necessary. MEOPAR is taking a pragmatic approach and will give due consideration on a case-by-case basis to the following:

  • Deadlines for progress reporting
  • Budget reallocations or exceptional charges to grants arising from travel/other restrictions
  • No-cost extensions
  • Restructuring of project deliverables and timelines for researcher mobility and collaborations, where the direct adverse impact has occurred

We ask that you remain in close contact with the Research Program Manager and Director Finance, regarding the impact COVID-19 is having on your research project.

Also—in response to the current situation, MEOPAR is stepping up its online training opportunities. Click here for a list of virtual resources for HQP that we’ll continue updating over the coming weeks.